Literature DB >> 10216286

Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells.

T Kinoshita1, Y Takahashi, T Sakashita, H Inoue, T Tanabe, T Yoshimoto.   

Abstract

There are two isoforms of cyclooxygenase (COX), COX-1 and COX-2. Recent epidemiological and experimental studies indicated a close relationship between COXs and the pathogenesis of colorectal cancer. The purpose of this study was to investigate the possible roles of both isoforms in the proliferation of colon carcinoma cells. A human colon carcinoma cell line, COLO 320DM, was transfected with an eukaryotic expression vector carrying cDNA of either COX-1 or COX-2, the expression of which was driven by a powerful elongation factor-1alpha promoter in pEF-BOS. Both COX-1- and COX-2-expressing cells possessed a similar enzyme activity, 8-10 nmol/10 min per mg protein. Growth rates of both cell lines were stimulated by about 2-fold during a course of culture for 7 days as compared with mock-transfected cells. Although COX-1 and COX-2 are believed to have fundamentally different biological roles, essentially no differences in growth stimulation were observed between the COX-1 and COX-2 overexpressions in our experiments. The reason may be explained by high levels of COX expression, and subtle differences between the both cell lines would be possibly apparent by lower expression levels. The stimulated growth of the COX-transfected cells was accompanied by increased DNA synthesis as assessed by [3H]thymidine incorporation. Furthermore, expression of epidermal growth factor receptor was markedly increased in these cells as examined by reverse transcription-polymerase chain reaction. A COX inhibitor, indomethacin, suppressed the stimulated growth, increased DNA synthesis and induction of epidermal growth factor receptor in COX-1- and COX-2-transfected cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216286     DOI: 10.1016/s1388-1981(99)00034-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells.

Authors:  Tong Ming Liu; Ying Nan Wu; Xi Min Guo; James Hoi Po Hui; Eng Hin Lee; Bing Lim
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

2.  Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.

Authors:  Ning-Bo Liu; Tao Peng; Chao Pan; Yu-Yu Yao; Bo Shen; Jing Leng
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme.

Authors:  Peter Sminia; T Rianne Stoter; Paul van der Valk; Paula H M Elkhuizen; Thea M Tadema; Gitta K Kuipers; W Peter Vandertop; M Vincent M Lafleur; Ben J Slotman
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

4.  Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.

Authors:  J J Sung; W K Leung; M Y Go; K F To; A S Cheng; E K Ng; F K Chan
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.

Authors:  N P Dowd; M Scully; S R Adderley; A J Cunningham; D J Fitzgerald
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 6.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

Review 7.  Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

Authors:  O C Trifan; T Hla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

8.  Association of PYGO2 and EGFR in esophageal squamous cell carcinoma.

Authors:  Meysam Moghbeli; Mohammad Reza Abbaszadegan; Moein Farshchian; Mehdi Montazer; Reza Raeisossadati; Abbas Abdollahi; Mohammad Mahdi Forghanifard
Journal:  Med Oncol       Date:  2013-03-03       Impact factor: 3.064

9.  Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells.

Authors:  J-I Ukegawa; Y Takeuchi; S Kusayanagi; K Mitamura
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-14       Impact factor: 4.553

10.  Expression of COX-2 in stomach carcinogenesis.

Authors:  Nora Manoukian Forones; Kharen Yaemi Kawamura; Helena Regina Comodo Segreto; Ricardo Artigiani Neto; Gustavo Rubino de Azevedo Focchi; Celina Tizuko Fujiyama Oshima
Journal:  J Gastrointest Cancer       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.